National Bio+Green Sciences LLC (NBGS) announces it’s strategic partnership with Dutch/German manufacturer of Corowell Rapid Covid-19 Symptom Screening Tests

National Bio+Green Sciences LLC (NBGS) announces it’s strategic partnership with Dutch/German manufacturer of Corowell Rapid Covid-19 Symptom Screening Tests.

● Corowell Rapid Covid-19 Symptom Screening Tests is an exceedingly accurate smell test that can quickly screen large groups of people.
● The impairment of the sense of smell (Anosmia / Hyposmia) is the main neurological symptom and one of the earliest and most commonly reported indicators of Covid-19 even within the first week of infection – long before any other symptom develops
● NBGS is the first to offer this exceptionally innovative screening test in North America

Branchburg, NJ 08/3/2021 National Bio+Green Sciences LLC (NBGS) is proud to announce a strategic partnership with the Corowell Group, the manufacturer of the Corowell Rapid & Objective Covid-19 Symptom Screening Test. This exclusive partnership will grant NBGS the distribution rights of the CE and FDA cleared screening tool for its North American pharmaceutical distribution channels.

The Corowell test, a simple, non-invasive screening test, is a highly accurate smell test that can quickly screen large groups of people and can fairly accurately indicate who has been exposed to COVID-19. The combination of the smell test and the Corowell app, where candidates are prompted to complete a quick screening questionnaire, significantly increases the likelihood of identifying “infection-suspicious” candidates. Those that have failed the screening test, should then undergo a more invasive “direct virus detection”, such as rapid Antigen test or RT-PCR to confirm whether they have a COVID-19 infection.

“As manufacturers we can easily identify a disruptor within our industry. We are very excited to offer this great innovative screening test that uses an easy, rapid & low-cost way to objectively identify suspected Covid-19 infections by testing the sense of smell”. Said Nikolaos Renieris, CEO of NBGS. “ Open the test kit, download the App on your phone and it's as easy as Scan-Scratch-Smell-Select-Pass! We see major application benefits for Schools, Universities, Venues, Stadiums, Airports, Cruise Lines, Prison Systems and many others.”

About the Corowell Rapid Covid-19 Screening Test
The Corowell test was developed to allow a quick, safe and easy screening that can be done anywhere by anyone. In addition to helping pre-screen larger groups of people in a fairly quick time, it is also highly accurate with a specificity of around 95%. The set up, in order to facilitate larger groups, is quite simple as once the kits are distributed the whole process only takes a few minutes. The kit was designed to be used in 5 steps and allows a user friendly experience and interface. The results are transmitted to your App as an encrypted digital pass that can be scanned and validated by officials using the Corowell Guard App at events, schools, airports, etc.

About Covid-19:
The novel coronavirus (SARS-CoV-2) is a new strain of a virus that causes a wide range of illnesses ranging from a common cold to severe respiratory diseases. Signs of infections include fever, cough, shortness of breath and other respiratory symptoms, and in particular an impairment of the smell and taste including the new variants as it focuses on the ACE 2 receptors in the first place that it reaches which is the olfactory pathway. In severe cases and on patience with pre-existing conditions the virus can cause pneumonia, severe acute respiratory syndrome, kidney failure and in some cases death can occur. For more information on the Virus please visit www.cdc.gov/coronavirus

NBGS response to the Covid-19 pandemic:
NBGS is well positioned with the proper infrastructure and equipment to develop and manufacture PPE for it’s clients. NBGS maintains one of the largest pandemic preparedness stockpiles in the nation. NBGS with its sister companies MaskEx USA (PPE-Mask and sanitization products) and ACS-Lab USA (a high complexity CLIA lab), have been actively supplying the area with top quality PPE and Covid test products throughout the pandemic.
About National Bio+Green Sciences (NBGS)
National Bio+Green Sciences LLC (NBGS) is located in Central Jersey, the Pharma Capital of the world. NBGS operates an FDA Registered Facility and is a contract manufacturer, labeler and supplier of medical/pharma products and devices. With over 30 years of industry knowledge and experience in the RX and OTC markets, NBGS is recognized as an innovator in the space.

About Corowell:
The Corowell Product line was developed by a group of Europe's most innovative MedTech entrepreneurs who have been creating several new businesses in the health-care & medical devices field, over the course of the last 30 years. Their focus lays heavily on identifying current problems and addressing them with smart and innovative technologies.

For more information about the partnership please visit us online: www.nbgsusa.com or send us an email sales@nbgsusa.com, phone: 908-255-4133.

National Bio+Green Sciences LLC (NBGS)
6b Culnen Dr.
Branchburg, NJ 08876
sales@nbgsusa.com

--

This release was published on openPR.